Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-025144
Filing Date
2025-05-13
Accepted
2025-05-13 16:43:45
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q carm-20250331.htm   iXBRL 10-Q 653878
2 EX-31.1 carm-20250331xexx3111.htm EX-31.1 10660
3 EX-31.2 carm-20250331xexx3121.htm EX-31.2 10545
4 EX-32.1 carm-20250331xexx3211.htm EX-32.1 4966
5 EX-32.2 carm-20250331xexx3221.htm EX-32.2 4812
  Complete submission text file 0001628280-25-025144.txt   4507732

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT carm-20250331.xsd EX-101.SCH 39403
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT carm-20250331_cal.xml EX-101.CAL 62985
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT carm-20250331_def.xml EX-101.DEF 108764
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT carm-20250331_lab.xml EX-101.LAB 548235
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT carm-20250331_pre.xml EX-101.PRE 336392
68 EXTRACTED XBRL INSTANCE DOCUMENT carm-20250331_htm.xml XML 452139
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 25940900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)